October 20, 2019
Vertex reimburses Cystic Fibrosis Medicines Symdeko for patients ages 12 and Older, and Orkambi in children ages 2 to 5, with certain CFTR mutations in Australia
Vertex has reimburseed Cystic Fibrosis Medicines Symdeko for patients ages 12 and Older, and Orkambi in children ages 2 to…